Prospective Multicenter Registry of Hybrid Coronary Artery Revascularization Combined With Surgical Bypass and Percutaneous Coronary Intervention Using Everolimus Eluting Metallic Stents
Sponsor: Teikyo University
Listed as NCT02894255, this PHASE4 trial focuses on Coronary Artery Disease and remains ongoing. Sponsored by Teikyo University, it has been updated 7 times since 2016, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Oct 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Enrolling By Invitation → Unknown Status
-
Jun 2018 — Oct 2018 [monthly]
Enrolling By Invitation PHASE4
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Enrolling By Invitation PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE4
First recorded
Sep 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Teikyo University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.